The role of bile acids and their TGR5 receptor in irritable bowel syndrome and diarrhoea

被引：4

作者：

Walters, Julian R. F. ^{[1
,2
]}

机构：

[1] Imperial Coll Healthcare NHS Trust, Dept Gastroenterol, London W12 0NN, England

[2] Hammersmith Hosp, Imperial Coll London, Div Digest Dis, London W12 0NN, England

来源：

DIGESTIVE AND LIVER DISEASE | 2021年 / 53卷 / 09期

关键词：

Irritable bowel syndrome; Functional diarrhoea; Bile acids; TGR5; MALABSORPTION; PREVALENCE; MICROBIOTA;

D O I：

10.1016/j.dld.2021.06.017

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

This commentary looks at recent findings relating to bile acids in patients with irritable bowel syndrome with diarrhoea (IBS-D). Bile acid diarrhoea is recognised to be a frequent, treatable cause of chronic diarrhoea, with a clinical picture which overlaps IBS-D. In the study - by Wei and colleagues, a large proportion of IBS-D patients were shown to have increased faecal bile acids, and an increase in primary bile acids, reflecting changes in bacterial metabolism. Expression of the colonic membrane bile acid receptor, TGR5, was associated with faecal bile acids and the severity of symptoms. (C) 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

引用

页码：1118 / 1119

页数：2

共 50 条

[31] Membrane bile acid receptor TGR5 - a new target in the study of metabolic, inflammatory and neoplastic diseases [J].

Drapkina, O. M. ;

Fomicheva, E. I. .

RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (03) :344-350

[32] Bowel Functions, Fecal Unconjugated Primary and Secondary Bile Acids, and Colonic Transit in Patients With Irritable Bowel Syndrome [J].

Shin, Andrea ;

Camilleri, Michael ;

Vijayvargiya, Priya ;

Busciglio, Irene ;

Burton, Duane ;

Ryks, Michael ;

Rhoten, Deborah ;

Lueke, Alan ;

Saenger, Amy ;

Girtman, Adam ;

Zinsmeister, Alan R. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (10) :1270-+

[33] Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia [J].

Chen, Min-Chan ;

Chen, Yi-Ling ;

Wang, Tzu-Wen ;

Hsu, Hui-Ping ;

Lai, Ming-Derg .

ONCOLOGY REPORTS, 2016, 36 (04) :1997-2008

[34] Interplay between bile acid metabolism and microbiota in irritable bowel syndrome [J].

Dior, M. ;

Delagreverie, H. ;

Duboc, H. ;

Jouet, P. ;

Coffin, B. ;

Brot, L. ;

Humbert, L. ;

Trugnan, G. ;

Seksik, P. ;

Sokol, H. ;

Rainteau, D. ;

Sabate, J. -M. .

NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 (09) :1330-1340

[35] Bile Acid and Gut Microbiota in Irritable Bowel Syndrome [J].

Min, Yang Won ;

Rezaie, Ali ;

Pimentel, Mark .

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 28 (04) :549-561

[36] Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders [J].

Camilleri, M. ;

Vazquez-Roque, M. I. ;

Carlson, P. ;

Burton, D. ;

Wong, B. S. ;

Zinsmeister, A. R. .

NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 (11) :995-E458

[37] The role of FODMAPs in irritable bowel syndrome [J].

Shepherd, Susan J. ;

Halmos, Emma ;

Glance, Simon .

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2014, 17 (06) :605-609

[38] Risk factors for chronic diarrhoea in the community in the absence of irritable bowel syndrome [J].

Chang, J. Y. ;

Locke, G. Richard, III ;

Schleck, C. D. ;

Zinsmeister, A. R. ;

Talley, N. J. .

NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (10) :1060-1067+e87

[39] Probiotics in Irritable Bowel Syndrome: A Review of Their Therapeutic Role [J].

Kumar, Lakshmi Satish ;

Pugalenthi, Lakshmi Sree ;

Ahmad, Mahlika ;

Reddy, Sanjana ;

Barkhane, Zineb ;

Elmadi, Jalal .

CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)

[40] Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome [J].

Durban, Ana ;

Abellan, Juan J. ;

Jimenez-Hernandez, Nuria ;

Artacho, Alejandro ;

Garrigues, Vicente ;

Ortiz, Vicente ;

Ponce, Julio ;

Latorre, Amparo ;

Moya, Andres .

FEMS MICROBIOLOGY ECOLOGY, 2013, 86 (03) :581-589

← 1 2 3 4 5 →